Chemicals and Drugs [D] » Chemical Actions and Uses [D27] » Pharmacologic Actions » Molecular Mechanisms of Pharmacological Action
Description
Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY. MeSH
Hierarchy View
Subtype Terms (32)
Alkylating Agents
3 drugs (2 approved, 1 experimental)
Angiotensin Receptor Antagonists
3 approved drugs
Antidiuretic Hormone Receptor Antagonists
Antimetabolites
9 drugs (6 approved, 3 experimental)
Antioxidants
39 drugs (8 approved, 31 experimental)
CCR5 Receptor Antagonists
2 approved drugs
Cytochrome P-450 Enzyme Inducers
Endothelin Receptor Antagonists
Enzyme Inhibitors
6 drugs (4 approved, 2 experimental)
Heparin Antagonists
1 approved drug
Immune Checkpoint Inhibitors
17 drugs (11 approved, 6 experimental)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (3)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
